Buy Y-Mabs Therapeutics Inc Stock | YMAB Stock Price & Latest News | Public
YMAB

Y-Mabs Therapeutics Inc

$0.00 (0.00%)Today

    About YMAB

    Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody-based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulato...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.34
    -0.67
    -1.01
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.65

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,65B
    Volume3,72k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$50.49
    1 Year Low$14.16
    Open$41.39
    High$43.59
    Low$41.39

    Buy any stock with any amount of money.

    Download the App
    Download the app